Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on April 18, 2005

Hypertension. 2005
Published online before print April 18, 2005, doi: 10.1161/01.HYP.0000165024.47728.f7
A more recent version of this article appeared on May 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
45/5/1024    most recent
01.HYP.0000165024.47728.f7v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bauer, N.
Right arrow Articles by Schoner, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bauer, N.
Right arrow Articles by Schoner, W.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ATENOLOL
*BENAZEPRIL HYDROCHLORIDE
*OUABAIN
Medline Plus Health Information
*Exercise for Children
*Exercise and Physical Fitness
Related Collections
Right arrow Other hypertension

Submitted on September 16, 2004
Revised on October 7, 2004

Ouabain-Like Compound Changes Rapidly on Physical Exercise in Humans and Dogs. Effects of {beta}-Blockade and Angiotensin-Converting Enzyme Inhibition

Natali Bauer; Jochen Müller-Ehmsen; Ulrike Krämer; Njde Hambarchian; Carsten Zobel; Robert H.G. Schwinger; Horst Neu; Ulrike Kirch; Ernst-Günther Grünbaum; and Wilhelm Schoner*

From the Clinic for Small Animal Internal Medicine and Forensic Affairs (N.B., H.N., E.-G.G.), Faculty of Veterinary Medicine, Justus-Liebig-University Giessen; Department of Internal Medicine III (J.M.-E., N.H., C.Z., R.H.G.S.), University of Cologne, Germany; Department of Internal Medicine (U.K.), University of Tübingen; Institute of Biochemistry and Endocrinology (U.K., W.S.), Faculty of Veterinary Medicine, Justus-Liebig-University Giessen, Giessen, Federal Republic of Germany.

* To whom correspondence should be addressed. E-mail: Wilhelm.Schoner{at}vetmed.uni-giessen.de.

Abstract--Ouabain, an inhibitor of the sodium pump, has been identified as a constituent of bovine adrenal glands. We were interested whether the release of this cardiotonic steroid is stimulated by physical exercise. Hence, athletes and healthy dogs were subjected to ergometry. Ouabain-like compound (OLC) was measured in venous blood by enzyme-linked immunosorbent assay as well as by 86Rb+ uptake inhibition (as ouabain equivalents). OLC increased in venous blood of athletes after 15 minutes of ergometry from 2.5±0.5 to 86.0±27.2 nmol/L (n=51; P<0.001), as did the concentration of a circulating inhibitor of the sodium pump from 7.3±1.7 to 129.8±51 nmol/L (ouabain equivalents, P<0.05). Half-maximal increase in heart rate and systolic blood pressure occurred at 5.1±1.2 nmol/L and at 30±1 nmol/L OLC, respectively. On rest, OLC decreased in humans and dogs with a half-life of 3 to 5 minutes. In beagles exposed to moderate exercise on a treadmill for 13 minutes, levels of OLC increased 46-fold (from 3.7±0.8 to 166.9±91.8 nmol/L; n=6; P<0.005). This effect was suppressed when the dogs had been treated for 3 weeks with the {beta}1-adrenergic receptor blocker atenolol or the angiotensin-converting enzyme inhibitor benazepril. We conclude that OLC changes rapidly during exercise and is under the control of norepinephrine and angiotensin II.


Key words: angiotensin-converting enzyme inhibitor • {beta}-blocker • circulation • endogenous ouabain • hypertension • sodium pump hypertension




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Nesher, M. Dvela, V. U. Igbokwe, H. Rosen, and D. Lichtstein
Physiological roles of endogenous ouabain in normal rats
Am J Physiol Heart Circ Physiol, December 1, 2009; 297(6): H2026 - H2034.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. Y. Bagrov, J. I. Shapiro, and O. V. Fedorova
Endogenous Cardiotonic Steroids: Physiology, Pharmacology, and Novel Therapeutic Targets
Pharmacol. Rev., March 1, 2009; 61(1): 9 - 38.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. L. Radzyukevich, J. B Lingrel, and J. A. Heiny
The cardiac glycoside binding site on the Na,K-ATPase {alpha}2 isoform plays a role in the dynamic regulation of active transport in skeletal muscle
PNAS, February 24, 2009; 106(8): 2565 - 2570.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
W. Schoner and G. Scheiner-Bobis
Role of endogenous cardiotonic steroids in sodium homeostasis
Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2723 - 2729.
[Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
W. Schoner and G. Scheiner-Bobis
Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth
Am J Physiol Cell Physiol, August 1, 2007; 293(2): C509 - C536.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Yoshika, Y. Komiyama, M. Konishi, T. Akizawa, T. Kobayashi, M. Date, S. Kobatake, M. Masuda, H. Masaki, and H. Takahashi
Novel Digitalis-Like Factor, Marinobufotoxin, Isolated From Cultured Y-1 Cells, and Its Hypertensive Effect in Rats
Hypertension, January 1, 2007; 49(1): 209 - 214.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Kotova, L. Al-Khalili, S. Talia, C. Hooke, O. V. Fedorova, A. Y. Bagrov, and A. V. Chibalin
Cardiotonic Steroids Stimulate Glycogen Synthesis in Human Skeletal Muscle Cells via a Src- and ERK1/2-dependent Mechanism
J. Biol. Chem., July 21, 2006; 281(29): 20085 - 20094.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
I. Larre, A. Ponce, R. Fiorentino, L. Shoshani, R. G. Contreras, and M. Cereijido
Contacts and cooperation between cells depend on the hormone ouabain
PNAS, July 18, 2006; 103(29): 10911 - 10916.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
I. Dostanic-Larson, J. N. Lorenz, J. W. Van Huysse, J. C. Neumann, A. E. Moseley, and J. B Lingrel
Physiological role of the {alpha}1- and {alpha}2-isoforms of the Na+-K+-ATPase and biological significance of their cardiac glycoside binding site
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R524 - R528.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. G. Forni and W. Schoner
Oabain-Like Compound Changes Rapidly on Physical Exercise in Humans and Dogs
Hypertension, October 1, 2005; 46(4): e13 - e13.
[Full Text] [PDF]


Home page
Mol. Biol. CellHome page
Z. Yuan, T. Cai, J. Tian, A. V. Ivanov, D. R. Giovannucci, and Z. Xie
Na/K-ATPase Tethers Phospholipase C and IP3 Receptor into a Calcium-regulatory Complex
Mol. Biol. Cell, September 1, 2005; 16(9): 4034 - 4045.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P.J. Hilton, W. McKinnon, and W. Schoner
Radioimmunoassays, Ouabain-Like Material, and Ouabain * Response
Hypertension, September 1, 2005; 46(3): e9 - e10.
[Full Text] [PDF]